Seeking Alpha

Pluristem's PLX cells safe in animal model

  • Pluristem Therapeutics (PSTI) rallies 3.6% premarket.
  • The company says its PLX cells "proved to be safe in an animal study assessing maternal and fetal toxicity."
  • When administered intramuscularly in pregnant rats, the PLX-PAD cells "did not result in any maternal or fetal toxicity."
  • Here's CEO Zami Aberman: "This study, together with the work performed by Dr. Brett Mitchell from Texas A&M College of Medicine,suggesting that our PLX-PAD cells are efficacious in preeclamptic animal models, is an important milestone towards our goal of initiating clinical trials for preeclampsia." (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: